← All stocks

STANDARD BIOTOOLS INC.

LAB Net buying

CIK 0001162194 #3739 in the set updated 18 Sep 2026

Bought (12 mo)

$14.44M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$14.44M

+$14.44M against sales at will

By person

10 insiders · 15 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Casdin Partners Master Fund, L.P. entity

Director

$14.44M (15)

—

+$14.44M

74,906,470

19.08%

$108.37M

+30.7%

Egholm Michael

President & CEO

—

6,137,704

1.56%

$8.88M

+305.8%

Casdin Eli

Director

—

3,053,169

0.7777%

$4.42M

+8.8%

Kim Hanjoon Alex

Chief Financial Officer

—

2,534,859

0.6457%

$3.67M

+339.6%

Mackay Sean

SVP & Chief Business Officer

—

1,480,823

0.3772%

$2.14M

+146.8%

Cox Troy

Director

—

475,702

0.1212%

$688.25K

+194.0%

Carey Thomas D.

Director

—

344,456

0.0877%

$498.36K

+698.7%

ELOI FENEL M

Director

—

335,299

0.0854%

$485.11K

+136.8%

Witney Frank

Director

—

309,978

0.0790%

$448.48K

+166.6%

HIBBS KATHY L

Director

—

236,836

0.0603%

$342.65K

+449.1%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 32

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 5

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 4,330,232

History held since 21 Oct 2016